Insider Shareholders with Direct Ownership of Seres Therapeutics, Inc. (MCRB)
This section provides a comprehensive overview of the insiders with direct ownership of Seres Therapeutics, Inc. (MCRB). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Seres Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
David Arkowitz
Chief Financial Officer |
177,326 | 8,005 | 182,442 $4.17 Million | 8 |
Feb 16, 2024
Reduced 2.11%
|
| 100,919 | 23,344 | 77,575 $1.77 Million | 13 |
Aug 16, 2024
Reduced 1.43%
|
|
| 63,492 | 0 | 63,492 $1.45 Million | 1 |
Jul 05, 2022
Added 50.0%
|
|
| 47,619 | 0 | 47,619 $1.09 Million | 1 |
Jul 05, 2022
Added 50.0%
|
|
|
Paula Cloghessy
Officer |
41,164 | 2,904 | 45,684 $1.04 Million | 3 |
Oct 30, 2023
Reduced 5.98%
|
| 60,146 | 20,271 | 39,875 $911,143 | 14 |
Feb 18, 2025
Reduced 9.97%
|
|
| 31,746 | 0 | 31,746 $725,396 | 1 |
Jul 05, 2022
Added 50.0%
|
|
|
Meryl Zausner
Director |
31,746 | 0 | 31,746 $725,396 | 1 |
Jul 05, 2022
Added 50.0%
|
| 209,675 | 49,470 | 10,609 $242,415 | 19 |
Aug 18, 2025
Reduced 2.0%
|
|
| 121,138 | 19,403 | 7,455 $170,346 | 19 |
Aug 18, 2025
Reduced 1.01%
|
|
| 137,245 | 39,370 | 5,215 $119,162 | 20 |
Aug 18, 2025
Reduced 1.12%
|
|
| 183,465 | 110,696 | 4,548 $103,921 | 21 |
Aug 18, 2025
Reduced 1.58%
|
|
| 3,589 | 0 | 3,589 $82,008 | 1 |
Nov 23, 2020
Added 50.0%
|